This protocol describes the conversion of skin fibroblasts into myoblasts and their differentiation into myotubes. The cell lines are derived from patients with neuromuscular disorders and can be used to investigate pathological mechanisms and to test therapeutic strategies.
Almeida, C. F., Frair, E. C., Huang, N., Neinast, R., McBride, K. L., Weiss, R. B., Flanigan, K. M., Wein, N. Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders. J. Vis. Exp. (170), e61991, doi:10.3791/61991 (2021).